KIRSTIE SCHIEFFLER: Open Payments
NPI 1952920324 · FAYETTEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 21 payments from 5 companies in 2025. Trend: 2023 $342 · 2024 $593 · 2025 $426
Food & beverage: $426
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $158 |
| GENZYME CORPORATION | 4 | $122 |
| Regeneron Healthcare Solutions, Inc. | 3 | $77 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
Products named: DUPIXENT, NUCALA, NEFFY, TEZSPIRE.
Industry payments across GA — which companies pay providers there.
